With low false positives and broad detection capabilities, Volition’s Nu.Q® test could reshape the $20B liquid biopsy market, as the company advances licensing talks with major diagnostic players. ...
Collaboration aims to enhance pharmaceutical innovation and expand access to high-quality healthcare solutions worldwide. ...
Strategic move strengthens Clario’s leadership in medical imaging and bolsters expertise in multiple sclerosis and neurological drug development....
Strategic Agreement Brings Evidence-Based Clinical Pathways to Radiation Oncology Workflows, Improving Care Quality and Efficiency ...
Approval paves the way for broader adoption of Baird Medical’s minimally invasive treatment for tumor ablation, expanding access to advanced cancer care in Indonesia. ...
The new solution leverages real-time data and AI-driven insights to enhance early sepsis detection, optimize clinical workflows, and improve patient outcomes. ...
The acquisition strengthens MoveUP’s AI capabilities, optimizing musculoskeletal diagnostics, predictive analytics, and personalized rehabilitation strategies for enhanced patient outcomes. ...
GentleBeam™ aims to enhance Image-Guided SRT for nonmelanoma skin cancer, reinforcing SkinCure Oncology’s commitment to patient-centered, nonsurgical care. ...
Zimmer Biomet Secures FDA Clearance for Persona® Revision SoluTion™ Femur, Expanding Options for Metal-Sensitive Knee Implant Patients...
Largest head-to-head TAVR study highlights Evolut’s lower bioprosthetic valve dysfunction and improved durability in patients with small aortic annulus, reinforcing clinical decision-making in transcatheter valve therapy....
